The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | |||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | ||||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | FIGI | (to the nearest dollar) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ACLARIS THERAPEUTICS INC | COM | 00461U105 | 8,419,700 | 1,040,754 | SH | SOLE | 1,040,754 | 0 | 0 | |||
| AEROVATE THERAPEUTICS INC | COM | 008064107 | 16,820,308 | 833,927 | SH | SOLE | 833,927 | 0 | 0 | |||
| AFFIMED N V | COM | N01045108 | 1,065,143 | 1,428,571 | SH | SOLE | 1,428,571 | 0 | 0 | |||
| AMBRX BIOPHARMA INC | SPONSORED ADS | 02290A102 | 29,423,307 | 3,298,577 | SH | SOLE | 3,298,577 | 0 | 0 | |||
| ANNEXON INC | COM | 03589W102 | 12,397,193 | 3,220,050 | SH | SOLE | 3,220,050 | 0 | 0 | |||
| AVALO THERAPEUTICS INC | COM NEW | 05338F207 | 1,750,000 | 1,000,000 | SH | SOLE | 1,000,000 | 0 | 0 | |||
| CABALETTA BIO INC | COM | 12674W109 | 16,318,786 | 1,973,251 | SH | SOLE | 1,973,251 | 0 | 0 | |||
| CELCUITY INC | COM | 15102K100 | 21,580,207 | 2,105,386 | SH | SOLE | 2,105,386 | 0 | 0 | |||
| COGENT BIOSCIENCES INC | COM | 19240Q201 | 52,708,902 | 4,884,977 | SH | SOLE | 4,884,977 | 0 | 0 | |||
| DICE THERAPEUTICS INC | COM | 23345J104 | 23,464,350 | 819,000 | SH | SOLE | 819,000 | 0 | 0 | |||
| ENLIVEN THERAPEUTICS INC | COM | 29337E102 | 48,489,710 | 2,214,142 | SH | SOLE | 2,214,142 | 0 | 0 | |||
| FULCRUM THERAPEUTICS INC | COM | 359616109 | 3,725,218 | 1,307,094 | SH | SOLE | 1,307,094 | 0 | 0 | |||
| GH RESEARCH PLC | ORDINARY SHARES | G3855L106 | 28,101,829 | 3,517,125 | SH | SOLE | 3,517,125 | 0 | 0 | |||
| KALVISTA PHARMACEUTICALS INC | COM | 483497103 | 22,925,003 | 2,916,667 | SH | SOLE | 2,916,667 | 0 | 0 | |||
| LYRA THERAPEUTICS INC | COM | 55234L105 | 1,857,582 | 924,170 | SH | SOLE | 924,170 | 0 | 0 | |||
| MERUS N V | COM | N5749R100 | 22,562,338 | 1,226,214 | SH | SOLE | 1,226,214 | 0 | 0 | |||
| MILESTONE PHARMACEUTICALS IN | COM | 59935V107 | 8,702,719 | 2,208,812 | SH | SOLE | 2,208,812 | 0 | 0 | |||
| PLIANT THERAPEUTICS INC | COM | 729139105 | 38,038,000 | 1,430,000 | SH | SOLE | 1,430,000 | 0 | 0 | |||
| RALLYBIO CORP | COM | 75120L100 | 1,533,318 | 268,532 | SH | SOLE | 268,532 | 0 | 0 | |||
| SAVARA INC | COM | 805111101 | 12,385,485 | 6,351,531 | SH | SOLE | 6,351,531 | 0 | 0 | |||
| TERNS PHARMACEUTICALS INC | COM | 880881107 | 42,855,140 | 3,619,522 | SH | SOLE | 3,619,522 | 0 | 0 | |||
| THESEUS PHARMACEUTICALS INC | COM | 88369M101 | 6,837,600 | 770,000 | SH | SOLE | 770,000 | 0 | 0 | |||
| TREVI THERAPEUTICS INC | COM | 89532M101 | 5,642,541 | 3,050,022 | SH | SOLE | 3,050,022 | 0 | 0 | |||
| VECTIVBIO HLDG AG | ORD SHS | H9060V101 | 15,879,660 | 1,866,000 | SH | SOLE | 1,866,000 | 0 | 0 | |||
| VIRIDIAN THERAPEUTICS INC | COM | 92790C104 | 68,684,566 | 2,699,865 | SH | SOLE | 2,699,865 | 0 | 0 | |||